Written by Megan Redshaw Defending children’s health
For the fifth time since the onset of the COVID pandemic in early 2020, Moderna’s share price has skyrocketed Produce a billionaire.
moderna head Dr. Stephen Hogg He is the latest shareholder and CEO of the company to join the “Three Dividers Club” – with an estimated fortune of $1.1 billion.
Hoge, 45, joined Moderna in 2012 and owns 0.4% of Moderna’s stock — worth $365 million — plus about $685 million in options. like the other Moderna Shareholders, Hoge frequently sells stock — including $65.5 million (before tax) between March 2020 and April 2021.
Activists say this generation of wealth highlights the stark inequality that has resulted from the pandemic, CNN reported.
“These billionaires are the human face of a lot of huge profits pharmaceutical “Companies are making their monopoly on these vaccines,” Ann Marriott, Oxfam’s director of health policy, said in a statement. “These vaccines were funded with public funds and should be, first and foremost, a global public good, not a private profit opportunity.”
Since February 2020, Moderna share price Gained more than 700%. Over the past month alone, the company’s stock is up 29%. During the same time frame, our modern applied to Emergency Use Permission From the U.S. Food and Drug Administration on a COVID vaccine in teens, and a plus Its expected production of the vaccine in 2021, from 800 million doses to one billion doses.
Taxpayers Pay the Bill for Vaccine Research
Such as Defender mentioned Previously Moderna .’s COVID Vaccine funded Almost entirely by American taxpayers. Through its partnership with the United States government, Moderna received Nearly 1 billion dollars for research and development in its field mRNA vaccineand up to $1.525 billion to deliver 100 million doses, with an option for another 400 million doses.
to me public citizen, The National Institutes of Health (National Institutes of Health) owns 50% of Moderna’s RNA vaccine, which the NIH helped develop under the National Institute of Allergy and Infectious Diseases (NIAID), which it manages Dr. Anthony Fauci.
As shown in People’s Vaccine, the US government I gave millions of dollars to Moderna as early as 2013 to help develop its mRNA technology. Meanwhile, the National Institutes of Health has also been developing new ways to target COVID spike proteins. When the file Corona virus appeared In Wuhan, China, National Institutes of Health I worked with our moderators To design and test a vaccine.
The US Biomedical Advanced Research Development Authority has provided an additional $483 million to our director to continue developing the vaccine and expanding manufacturing.
Fauci and NIAID have a financial incentive to push Moderna over competitors’ COVID vaccines — because Fauci personally, and others on the task force, have financial share In Moderna Vaccine. Fauci and Four of his chosen deputies will split Hundreds of millions of dollars In royalties with Moderna Corporation from the sale of the vaccine.
Moderna continues to ignore its vaccine problems
Moderna’s stock has been rising steadily, and its top executives have benefited accordingly, despite the growing number of reports of post-vaccine infections and deaths.
according to Latest data From the Centers for Disease Control and Prevention (CDC) Adverse Event Reporting System (VAERS), between December 14, 2020 and June 4, totaling 329,021 Total negative events COVID vaccines have been reported to follow, including 5,888 death cases and 28441 Serious injury reports.
Such as Defender mentioned This week, Simone Scott, a 19-year-old student at Northwestern University in Evanston, Illinois, He passed away on June 11 A complication of a heart transplant she underwent after she developed what her doctors believe was myocarditis after her second dose of the Moderna COVID vaccine.
its source Wake up times